1.1800
01-November-24 14:59:56
15 minutes delayed
Stocks
-0.0200
-1.67%
Today's range
1.1600 - 1.2185
ISIN
N/A
Source
NASDAQ
Ocuphire Completes Enrollment in MIRA-2 Phase 3 Clinical Trial Investigating Nyxol® for Reversal of Mydriasis
06 Jan 2021 06:00:01 By Nasdaq GlobeNewswire